183 related articles for article (PubMed ID: 5343928)
1. [Clinical tests using pyridinol carbamate on the arterial circulation and blood coagulation in patients with arteriosclerosis obliterans].
De Soldati L; Castro CM; Grilli H; Reussi J
Prensa Med Argent; 1969 May; 56(12):546-53. PubMed ID: 5343928
[No Abstract] [Full Text] [Related]
2. [Effect of pyridinol carbamate (Anginin) in peripheral arterial blood circulation disorders].
Heisig N; Westermann KW; Stolterfoht CA; Zaki J
Med Klin; 1970 Dec; 65(52):2289-93. PubMed ID: 5522670
[No Abstract] [Full Text] [Related]
3. [Effect of pyridinolcarbamate on blood coagulation and thrombolysis in patients with arteriosclerosis obliterans].
Hess H; Goossens N; Keil-Kuri E; Zollner R; Meyer A
Vasa; 1972; 1(3):206-11. PubMed ID: 5076123
[No Abstract] [Full Text] [Related]
4. [Anginin (pyridinol carbamate) therapy of coronary atherosclerosis and obliterating atherosclerosis of the arteries of the lower extremities].
Liusov VA; Belousov IuB; Martynov AI; Koroleva SA; Zimin VS
Kardiologiia; 1972 Nov; 12(11):39-45. PubMed ID: 4655879
[No Abstract] [Full Text] [Related]
5. [Evaluation of the action of p-chlorophenoxy alpha-isobutyrate of 3-hydroxymethyl pyridine hydrochloride on peripheral circulation. Rheographic and radioisotope studies].
Modica G; Ferrante R
Minerva Cardioangiol; 1973 Dec; 21(12):769-74. PubMed ID: 4592148
[No Abstract] [Full Text] [Related]
6. [Short-term heparin therapy in obliterating arteriopathies of the lower limbs].
Arrigo F; Coglitore S; Giannetto M; Bramanti O; Barbera C; Consolo F
Boll Soc Ital Cardiol; 1977; 22(3):273-82. PubMed ID: 617274
[No Abstract] [Full Text] [Related]
7. [Clinical and plethysmographic evaluation in patients with peripheral arteriopathies treated with pyridinolcarbamate].
Lucero Eseverri JA; Fajardo JD; Velles Aguirre L; Quijano E; Ciliberti E; Lucarelli R
Prensa Med Argent; 1970 Apr; 57(8):394-8. PubMed ID: 5517707
[No Abstract] [Full Text] [Related]
8. [Treatment of experimental and human athero- sclerosis by a bradykinin antagonist, pyridinol carbamate. (Preliminary report)].
Shimamoto T; Numano F; Fujita T; Atsumi T
Rev Atheroscler (Paris); 1967; 9(2):294-306. PubMed ID: 6064255
[No Abstract] [Full Text] [Related]
9. [Contribution of pyridinol-carbamate in ophthalmologic therapeutics].
Pouliquen Y; Guyot-Argenton C
Nouv Presse Med; 1972 Jan; 1(3):199-200. PubMed ID: 5061538
[No Abstract] [Full Text] [Related]
10. Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.
Shimamoto T; Atsumi T
Jpn Heart J; 1965 Sep; 6(5):407-15. PubMed ID: 5294603
[No Abstract] [Full Text] [Related]
11. [The effect of eledoisin on the rheogram in arteriosclerosis obliterans].
Szám I; Kusztos D; Csapó G
Arzneimittelforschung; 1966 Dec; 16(12):1671-3. PubMed ID: 6014806
[No Abstract] [Full Text] [Related]
12. [Clinical trial of a long-acting vasodilator agent in chronic peripheral obliterating arteriopathy of a sclerotic nature].
Gemma GB; Ghezzi P; Cavaliere P
Minerva Cardioangiol; 1969 May; 17(5):324-32. PubMed ID: 5785730
[No Abstract] [Full Text] [Related]
13. Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography.
Motomiya T; Atsumi T; Isokane N; Yamashita S; Sano T
Jpn Heart J; 1970 Sep; 11(5):433-49. PubMed ID: 4921577
[No Abstract] [Full Text] [Related]
14. Treatment of occlusive diseases of the arteries in the limbs with pyridinol-carbamate.
Matsumoto K; Sato K; Tanaka S
Jpn Heart J; 1966 Jan; 7(1):87-93. PubMed ID: 5295647
[No Abstract] [Full Text] [Related]
15. [Effect of fibrinolysis activation on the peripheral blood circulation in occlusive vascular diseases].
Bielawiec M; Lukjan H
Med Monatsschr; 1971 Jul; 25(7):312-4. PubMed ID: 5563915
[No Abstract] [Full Text] [Related]
16. Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliterans.
Shimamoto T; Atsumi T; Yamashita S; Motomiya T; Isokane N; Ishioka T; Sakuma A
Am Heart J; 1970 Jan; 79(1):5-19. PubMed ID: 4903137
[No Abstract] [Full Text] [Related]
17. [Pyridinol-carbamate and atherosclerosis. Clinical studies and animal experiments].
de Oliveira JM
Hospital (Rio J); 1968 Sep; 74(3):799-806. PubMed ID: 5303765
[No Abstract] [Full Text] [Related]
18. [Rheographic study of the activity of some vasoactive drugs on peripheral arterial circulation].
Capitanucci P; Martinelli M; De Gregorio M
Minerva Cardioangiol; 1968 Nov; 16(11):1074-82. PubMed ID: 5707452
[No Abstract] [Full Text] [Related]
19. Results obtained with prodectin in arteriosclerotic arterial obliteration of the lower extremities.
Hunyi L
Ther Hung; 1976; 24(2):67-71. PubMed ID: 982342
[No Abstract] [Full Text] [Related]
20. [Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
Roztocil K; Oliva I; Linhart J; Prerovský I; Modr Z
Cas Lek Cesk; 1976 Aug; 115(33-34):1051-5. PubMed ID: 975177
[No Abstract] [Full Text] [Related]
[Next] [New Search]
